@article{8c35ca27286b45fcaf282d9c29b65995,
title = "The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer.",
author = "Scariano, \{John K.\} and Eric Treat and Frances Alba and Harold Nelson and Ness, \{Scott A.\} and Smith, \{Anthony Y.\}",
note = "Background: Emerging evidence indicates that testosterone (T), and not dihydrotestosterone (DHT), is the most relevant androgen that promotes carcinogenesis in the prostate. Steroid 5-alpha reductase type II (SRD5A2) catalyzes the irreversible conversion of T to DHT in male reproductive organs.",
year = "2008",
month = dec,
day = "1",
doi = "10.1002/PROS.20842",
language = "American English",
volume = "68",
journal = "The Prostate",
number = "16",
}